208 related articles for article (PubMed ID: 11513839)
1. Serotonergic effects and extracellular brain levels of eletriptan, zolmitriptan and sumatriptan in rat brain.
Johnson DE; Rollema H; Schmidt AW; McHarg AD
Eur J Pharmacol; 2001 Aug; 425(3):203-10. PubMed ID: 11513839
[TBL] [Abstract][Full Text] [Related]
2. The in vivo pharmacological profile of eletriptan (UK-116,044): a potent and novel 5-HT(1B/1D) receptor agonist.
Gupta P; Butler P; Shepperson NB; McHarg A
Eur J Pharmacol; 2000 Jun; 398(1):73-81. PubMed ID: 10856450
[TBL] [Abstract][Full Text] [Related]
3. Characterisation of the 5-HT receptor binding profile of eletriptan and kinetics of [3H]eletriptan binding at human 5-HT1B and 5-HT1D receptors.
Napier C; Stewart M; Melrose H; Hopkins B; McHarg A; Wallis R
Eur J Pharmacol; 1999 Mar; 368(2-3):259-68. PubMed ID: 10193663
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological analysis of contractile effects of eletriptan and sumatriptan on human isolated blood vessels.
van den Broek RW; MaassenVanDenBrink A; de Vries R; Bogers AJ; Stegmann AP; Avezaat CJ; Saxena PR
Eur J Pharmacol; 2000 Oct; 407(1-2):165-73. PubMed ID: 11050304
[TBL] [Abstract][Full Text] [Related]
5. The antimigraine 5-HT 1B/1D receptor agonists, sumatriptan, zolmitriptan and dihydroergotamine, attenuate pain-related behaviour in a rat model of trigeminal neuropathic pain.
Kayser V; Aubel B; Hamon M; Bourgoin S
Br J Pharmacol; 2002 Dec; 137(8):1287-97. PubMed ID: 12466238
[TBL] [Abstract][Full Text] [Related]
6. Serotonin 5HT1B/1D receptor agonists abolish NMDA receptor-evoked enhancement of nitric oxide synthase activity and cGMP concentration in brain cortex slices.
Stepień A; Chalimoniuk M; Strosznajder J
Cephalalgia; 1999 Dec; 19(10):859-65. PubMed ID: 10668104
[TBL] [Abstract][Full Text] [Related]
7. Characterisation of the contractile activity of eletriptan at the canine vascular 5-HT1B receptor.
Gupta P; Scatchard J; Napier C; McHarg A; Wallis R
Eur J Pharmacol; 1999 Feb; 367(2-3):283-90. PubMed ID: 10079003
[TBL] [Abstract][Full Text] [Related]
8. SB-272183, a selective 5-HT(1A), 5-HT(1B) and 5-HT(1D) receptor antagonist in native tissue.
Watson J; Roberts C; Scott C; Kendall I; Collin L; Day NC; Harries MH; Soffin E; Davies CH; Randall AD; Heightman T; Gaster L; Wyman P; Parker C; Price GW; Middlemiss DN
Br J Pharmacol; 2001 Jul; 133(6):797-806. PubMed ID: 11454652
[TBL] [Abstract][Full Text] [Related]
9. Spotlight on eletriptan in migraine.
McCormack PL; Keating GM
CNS Drugs; 2006; 20(11):961-4. PubMed ID: 17044732
[TBL] [Abstract][Full Text] [Related]
10. [Pharmacological, pharmacokinetic and clinical profile of eletriptan (Relpax), a new triptan for migraine].
Omote M
Nihon Yakurigaku Zasshi; 2003 Jul; 122(1):93-101. PubMed ID: 12843576
[TBL] [Abstract][Full Text] [Related]
11. Effects of chronic sumatriptan and zolmitriptan treatment on 5-HT receptor expression and function in rats.
Reuter U; Salomone S; Ickenstein GW; Waeber C
Cephalalgia; 2004 May; 24(5):398-407. PubMed ID: 15096229
[TBL] [Abstract][Full Text] [Related]
12. Eletriptan.
Gawel MJ; Grujich NN
Expert Opin Investig Drugs; 2001 Oct; 10(10):1869-74. PubMed ID: 11772292
[TBL] [Abstract][Full Text] [Related]
13. Eletriptan: pharmacological differences and clinical results.
Giffin N
Curr Med Res Opin; 2001; 17 Suppl 1():s59-62. PubMed ID: 12463280
[TBL] [Abstract][Full Text] [Related]
14. Eletriptan review.
Färkkilä M; Kallela M
Expert Opin Pharmacother; 2005 Apr; 6(4):625-30. PubMed ID: 15934888
[TBL] [Abstract][Full Text] [Related]
15. Receptor specificity and trigemino-vascular inhibitory actions of a novel 5-HT1B/1D receptor partial agonist, 311C90 (zolmitriptan).
Martin GR; Robertson AD; MacLennan SJ; Prentice DJ; Barrett VJ; Buckingham J; Honey AC; Giles H; Moncada S
Br J Pharmacol; 1997 May; 121(2):157-64. PubMed ID: 9154322
[TBL] [Abstract][Full Text] [Related]
16. Agonist-directed trafficking explaining the difference between response pattern of naratriptan and sumatriptan in rabbit common carotid artery.
Akin D; Onaran HO; Gurdal H
Br J Pharmacol; 2002 May; 136(2):171-6. PubMed ID: 12010764
[TBL] [Abstract][Full Text] [Related]
17. The effect of SB-236057-A, a selective 5-HT1B receptor inverse agonist, on in vivo extracellular 5-HT levels in the freely-moving guinea-pig.
Roberts C; Hatcher P; Hagan JJ; Austin NE; Jeffrey P; Wyman P; Gaster LM; Routledge C; Middlemiss DN
Naunyn Schmiedebergs Arch Pharmacol; 2000 Aug; 362(2):177-83. PubMed ID: 10961381
[TBL] [Abstract][Full Text] [Related]
18. Effects of acute or chronic administration of anti-migraine drugs sumatriptan and zolmitriptan on serotonin synthesis in the rat brain.
Dobson CF; Tohyama Y; Diksic M; Hamel E
Cephalalgia; 2004 Jan; 24(1):2-11. PubMed ID: 14687006
[TBL] [Abstract][Full Text] [Related]
19. 5-Hydroxytryptamine(1F) receptors do not participate in vasoconstriction: lack of vasoconstriction to LY344864, a selective serotonin(1F) receptor agonist in rabbit saphenous vein.
Cohen ML; Schenck K
J Pharmacol Exp Ther; 1999 Sep; 290(3):935-9. PubMed ID: 10454462
[TBL] [Abstract][Full Text] [Related]
20. Eletriptan: a review of its use in the acute treatment of migraine.
McCormack PL; Keating GM
Drugs; 2006; 66(8):1129-49. PubMed ID: 16789799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]